Washington University in St. LouisSt. Louis, Missouri, United States
Disclosure information not submitted.
Paper 22 - A PHASE II STUDY OF CABOZANTINIB AND TEMOZOLOMIDE IN PATIENTS WITH UNRESECTABLE OR METASTATIC LEIOMYOSARCOMA AND OTHER SOFT TISSUE SARCOMAS
Thursday, November 2, 20234:00 PM – 5:30 PM